Slow release device eliminates bladder cancer in 82% of patients
A new slow-release chemotherapy system may be a more effective treatment for common bladder cancer than current therapy, according to results of a new clinical trial.
Could GLP-1 weight-loss drugs boost survival for colon cancer patients?
Colon cancer patients taking GLP-1 medications were less than half as likely to die within five years compared to those who weren’t on the drugs. – Image credit UC San Diego Today CANCER DIGEST – Nov. 15, 2025 – An analysis of data from nearly 7,000 colon cancer patients treated at cancer centers throughout California showed that patients who were taking a class of drug called glucagon-like peptide-1 (GLP-1) were more likely to survive compared to similar patients who were no
Niraparib nearly doubles progression-free survival in prostate cancer with specific genetic mutations
Men with prostate cancer whose tumors have specific genetic mutations saw a nearly 50 percent reduction in the risk of cancer progression when they received naraparib.
A new injectable cancer drug may offer hope to people with recurrent head and neck cancer
A simple injection of a new type of drug may offer new hope for patients whose head an neck cancers returns after chemotherapy and immunotherapy, results of an ongoing early phase clinical trial show.
A new blood test may detect HPV-linked throat cancer up to 10 years before diagnosis
A new blood test may detect throat cancer up to 10 years before diagnosis
Living near a Superfund pollution site may boost risk of aggressive types of breast cancer
Women diagnosed with breast cancer have a higher risk of aggressive and hard to treat cancers if they live near an EPA designated Superfund site.
